Review



goat anti flotillin 1  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Novus Biologicals goat anti flotillin 1
    Goat Anti Flotillin 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/Flotillin-1+Antibody/pm34843091-42-30-35
    Average 90 stars, based on 6 article reviews
    goat anti flotillin 1 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease Severance
    Article Snippet: P-Tau217 was detected using the rabbit polyclonal antibody to Tau phosphorylated on threonine 217 (Thermo Fisher, cat. #44,744); ABCA1—using mouse monoclonal anti-ABCA1 antibody H10 (Abcam, cat. #ab18180); and flotillin 1—using goat anti-flotillin 1 polyclonal antibody (Novus Biologicals, cat. #NB1001043).

    Article Title: Abundance of Nef and p-Tau217 in brains of individuals diagnosed with HIV-associated neurocognitive disorders correlate with disease severance
    Article Snippet: P-Tau217 was detected using the rabbit polyclonal antibody to Tau phosphorylated on Threonine 217 (Thermofisher (Waltham, MA), cat. #44744); ABCA1 – using mouse monoclonal anti-ABCA1 antibody H10 (Abcam (Cambridge, MA), cat. #ab18180); and flotillin 1 – using goat anti-flotillin 1 polyclonal antibody (Novus Biologicals (Littleton, Co), cat. #NB1001043).

    Article Title: Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease Severance.
    Article Snippet: P-Tau217 was detected using the rabbit polyclonal antibody to Tau phosphorylated on threonine 217 (Thermo Fisher, cat. #44,744); ABCA1—using mouse monoclonal anti-ABCA1 antibody H10 (Abcam, cat. #ab18180); and flotillin 1—using goat anti-flotillin 1 polyclonal antibody (Novus Biologicals, cat. #NB1001043).



    Similar Products

    91
    Bio-Techne corporation goat polyclonal anti human flotillin 1
    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for <t>flotillin</t> <t>1</t> (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .
    Goat Polyclonal Anti Human Flotillin 1, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/Flotillin-1+Antibody/pmc09733434-10-0-6
    Average 91 stars, based on 1 article reviews
    goat polyclonal anti human flotillin 1 - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    95
    Bio-Techne corporation anti human flotillin 1 goat polyclonal antibody
    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for <t>flotillin</t> <t>1</t> (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .
    Anti Human Flotillin 1 Goat Polyclonal Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/Goat+anti-Human+IgG%2FIgA%2FIgM%2FIgD+(H%2BL)+Secondary+Antibody/pmc09733434-282-24-30
    Average 95 stars, based on 1 article reviews
    anti human flotillin 1 goat polyclonal antibody - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Novus Biologicals goat anti flotillin 1
    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for <t>flotillin</t> <t>1</t> (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .
    Goat Anti Flotillin 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/Flotillin-1+Antibody/pm34843091-42-30-35
    Average 90 stars, based on 1 article reviews
    goat anti flotillin 1 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology goat anti flotillin 1
    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for <t>flotillin</t> <t>1</t> (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .
    Goat Anti Flotillin 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/Flotillin-1+Antibody/pm33434618-90-9-12
    Average 95 stars, based on 1 article reviews
    goat anti flotillin 1 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    99
    Danaher Inc goat polyclonal antibody anti flotillin 1
    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for <t>flotillin</t> <t>1</t> (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .
    Goat Polyclonal Antibody Anti Flotillin 1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/Goat+polyclonal+Anti-GST3+%2F+GST+pi+antibody/pmc08150437-85-6-15
    Average 99 stars, based on 1 article reviews
    goat polyclonal antibody anti flotillin 1 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Danaher Inc goat polyclonal antibody anti flotillin 1 flot 1
    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for <t>flotillin</t> <t>1</t> (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .
    Goat Polyclonal Antibody Anti Flotillin 1 Flot 1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/Goat+polyclonal+Anti-GST3+%2F+GST+pi+antibody/pmc06914892-48-14-21
    Average 99 stars, based on 1 article reviews
    goat polyclonal antibody anti flotillin 1 flot 1 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    BioIVT Inc goat f(ab') 2 anti-rabbit igg (horseradish peroxidase conjugated) for flotillin-1, cd81, and annexin-2
    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for <t>flotillin</t> <t>1</t> (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .
    Goat F(ab') 2 Anti Rabbit Igg (Horseradish Peroxidase Conjugated) For Flotillin 1, Cd81, And Annexin 2, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+flotillin+1/anti+cd8/pmc05270547-303-15-19
    Average 90 stars, based on 1 article reviews
    goat f(ab') 2 anti-rabbit igg (horseradish peroxidase conjugated) for flotillin-1, cd81, and annexin-2 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for flotillin 1 (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .

    Journal: Cell reports

    Article Title: Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells

    doi: 10.1016/j.celrep.2022.111674

    Figure Lengend Snippet: (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for flotillin 1 (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .

    Article Snippet: goat polyclonal anti-human Flotillin 1 , Bio-Techne , cat#NB100-1043.

    Techniques: In Vitro, Western Blot, Flow Cytometry, Staining, Activation Assay, Expressing, RNA Sequencing Assay, Enzyme-linked Immunosorbent Assay, Comparison, Produced, Concentration Assay

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells

    doi: 10.1016/j.celrep.2022.111674

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: goat polyclonal anti-human Flotillin 1 , Bio-Techne , cat#NB100-1043.

    Techniques: Virus, Plasmid Preparation, Recombinant, Modification, Staining, RNA HS Assay, SYBR Green Assay, Membrane, Isolation, Cell Fractionation, Lysis, Blocking Assay, Enzyme-linked Immunosorbent Assay, Software, Western Blot

    (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for flotillin 1 (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .

    Journal: Cell reports

    Article Title: Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells

    doi: 10.1016/j.celrep.2022.111674

    Figure Lengend Snippet: (A) Diagram of in vitro experiments in this study. Monocytes treated with exNef or exCont in the presence or absence of methyl-β-cyclodextrin (MβCD), fluvastatin (Flu), or picropodophyllin (PPP) were analyzed by western blotting (WB) for flotillin 1 (Flot1) or by flow cytometry for lipid rafts (staining with CTB) and IGF1R. After differentiation in the presence of M-CSF, MDMs were characterized by t-SNE for activation markers or by ddPCR for gene expression. Following LPS stimulation, gene expression was characterized by RNA-seq and cytokine production measured by ELISA. See also and . (B) Analysis of TNF-α and IL-6 production by LPS-treated MDMs. The graph shows fold increase of cytokine production by exNef-treated over exCont-treated cells from 8 donors (8 biological replicates, 3 technical replicates for each donor), analyzed by Friedman multiple comparison test with Dunn’s correction. Adjusted p values are shown above bars. (C) Dose response analysis. The graph shows mean ± SEM (3 technical replicates of cells from a single donor) fold increase of TNF-α produced by MDMs exposed to exNef with indicated concentrations of Nef versus MDM exposed to exCont at the same concentration of EVs. (D) Gene set enrichment analysis (GSEA) showing normalized enrichment scores for genes differentially expressed between exNef and exCont and participating in the inflammatory response (left panel) and cytokine pathway (right panel); the gene sets were obtained from BioCarta. (E) Leading edge analysis shows that a number of cytokine genes drive the changes of pathways dysregulated by exNef. See also - .

    Article Snippet: Capillaries with immobilized proteins were blocked with KPL Detection Block (5X) (SeraCare Life Sciences, Gaithersburg, MD) for 60 min, and then incubated with primary anti-human Flotillin 1 goat polyclonal antibody (Bio-Techne) or anti-hβ-actin mouse monoclonal antibody (R&D) for 60 min. After a wash step, HRP-conjugated anti-goat or near infrared (NIR) fluorescent dye-conjugated anti-mouse secondary antibody from Bio-Techne was added for 30 min to capillaries.

    Techniques: In Vitro, Western Blot, Flow Cytometry, Staining, Activation Assay, Expressing, RNA Sequencing Assay, Enzyme-linked Immunosorbent Assay, Comparison, Produced, Concentration Assay

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells

    doi: 10.1016/j.celrep.2022.111674

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: Capillaries with immobilized proteins were blocked with KPL Detection Block (5X) (SeraCare Life Sciences, Gaithersburg, MD) for 60 min, and then incubated with primary anti-human Flotillin 1 goat polyclonal antibody (Bio-Techne) or anti-hβ-actin mouse monoclonal antibody (R&D) for 60 min. After a wash step, HRP-conjugated anti-goat or near infrared (NIR) fluorescent dye-conjugated anti-mouse secondary antibody from Bio-Techne was added for 30 min to capillaries.

    Techniques: Virus, Plasmid Preparation, Recombinant, Modification, Staining, RNA HS Assay, SYBR Green Assay, Membrane, Isolation, Cell Fractionation, Lysis, Blocking Assay, Enzyme-linked Immunosorbent Assay, Software, Western Blot